Browse the detailed record of transactions filed by Mr. Gagan Harsh Sharma. Officer active across 1 company, notably Bliss GVS Pharma Limited. Aggregated, 10 disclosures have been logged. History available since 21 May 2025. The latest transaction was filed on 16 December 2025 (Purchase). Regulator: SEBI (PIT + SAST). All data is openly available.
Declarations 10 total
2,123 shares @ ₹140.9411 1.1% of flow Equity Shares SEBI:e5331d93a677845be060bde6663945a19b04f748
Ideal exit: 12 Sept 2026 (T+270) 10,000 shares @ ₹144.10 5.6% of flow Equity Shares SEBI:3d6c2a97a15ffe508a7b9cdb869c2e8e999026c6
Ideal exit: 8 Sept 2026 (T+270) 5,000 shares @ ₹142.10 2.7% of flow Equity Shares SEBI:6f41458204dda270481a988495937637af1ab0ca
Ideal exit: 11 Sept 2026 (T+270) 26,056 shares @ ₹149.2792 16.0% of flow Equity Shares SEBI:cb9f30fb380109af0d1037a12a3948ecc9a564d5
Ideal exit: 21 Mar 2026 (T+270) 6,762 shares @ ₹138.2786 3.8% of flow Equity Shares SEBI:86253f580105cf06d4cc172182970eda521b5c19
Ideal exit: 20 Mar 2026 (T+270) 46,657 shares @ ₹136.7018 26.7% of flow Equity Shares SEBI:2e39cc6505e8fdfbe561c39078963522b0c1ebad
Ideal exit: 6 Mar 2026 (T+270) 1,970 shares @ ₹136.7294 1.1% of flow Equity Shares SEBI:71515f8a7ec688867c64ea71ce9d6aabeea741af
Ideal exit: 7 Mar 2026 (T+270) 4,707 shares @ ₹121.4818 2.4% of flow Equity Shares SEBI:80d2900426a59bb30a3e6f86d849b3cf72e56384
Ideal exit: 16 Feb 2026 (T+270) 37,258 shares @ ₹121.1977 19.0% of flow Equity Shares SEBI:9d39608128e8f4236db72ea3755ece78f0f96332
Ideal exit: 15 Feb 2026 (T+270) 41,605 shares @ ₹121.4676 21.5% of flow Equity Shares SEBI:ff66561d9cc8454c468aac534952e81539146ce4
Ideal exit: 14 Feb 2026 (T+270)